Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 0.8800
-0.0900 (-9.28%)
At close: Sep 9, 2025
Observe Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Operating Revenue | 16.58 | 17.23 | 27.94 | 19.52 | 24.04 | 2.96 | Upgrade |
Other Revenue | 1.26 | 1.26 | - | - | - | - | Upgrade |
| 17.83 | 18.48 | 27.94 | 19.52 | 24.04 | 2.96 | Upgrade | |
Revenue Growth (YoY) | -36.55% | -33.85% | 43.14% | -18.80% | 711.96% | 1572.88% | Upgrade |
Cost of Revenue | 15.71 | 15.41 | 18.66 | 14.34 | 14.52 | 1.98 | Upgrade |
Gross Profit | 2.12 | 3.07 | 9.29 | 5.18 | 9.52 | 0.99 | Upgrade |
Selling, General & Admin | 13.11 | 15.29 | 24.22 | 27.31 | 17.26 | 10 | Upgrade |
Other Operating Expenses | 15.1 | 17.81 | 28.02 | 26.08 | 20.72 | 15.91 | Upgrade |
Operating Expenses | 42.06 | 47.47 | 66.39 | 64.32 | 41.44 | 29.07 | Upgrade |
Operating Income | -39.94 | -44.4 | -57.1 | -59.14 | -31.93 | -28.09 | Upgrade |
Interest Expense | -10.92 | -9.55 | -6.65 | -3.82 | -3.33 | -2.53 | Upgrade |
Interest & Investment Income | 1.78 | 1.78 | 0.06 | 0.28 | - | - | Upgrade |
Currency Exchange Gain (Loss) | -0.1 | -5.42 | -4.28 | 1.64 | 4.64 | 3.85 | Upgrade |
Other Non Operating Income (Expenses) | 1.99 | -0.02 | -1.82 | 0.65 | -0.43 | -0.13 | Upgrade |
EBT Excluding Unusual Items | -47.19 | -57.61 | -69.78 | -60.39 | -31.04 | -26.9 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -4.62 | - | Upgrade |
Impairment of Goodwill | -2.68 | -2.68 | -67.11 | - | - | - | Upgrade |
Other Unusual Items | 1.56 | 1.56 | 1.81 | 9.67 | 9.34 | -9.97 | Upgrade |
Pretax Income | -52.34 | -58.73 | -135.08 | -50.73 | -26.32 | -36.87 | Upgrade |
Income Tax Expense | -0.02 | - | 0.02 | 0.08 | - | - | Upgrade |
Net Income | -52.33 | -58.73 | -135.1 | -50.8 | -26.32 | -36.87 | Upgrade |
Net Income to Common | -52.33 | -58.73 | -135.1 | -50.8 | -26.32 | -36.87 | Upgrade |
Shares Outstanding (Basic) | 18 | 15 | 4 | 3 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 18 | 15 | 4 | 3 | 1 | 1 | Upgrade |
Shares Change (YoY) | 113.99% | 297.36% | 22.13% | 140.67% | 18.29% | 33.64% | Upgrade |
EPS (Basic) | -2.85 | -3.85 | -35.17 | -16.15 | -20.14 | -33.37 | Upgrade |
EPS (Diluted) | -2.89 | -3.90 | -35.17 | -16.20 | -20.14 | -33.37 | Upgrade |
Free Cash Flow | -20.21 | -29.27 | -32.47 | -52.74 | -22.34 | -22.88 | Upgrade |
Free Cash Flow Per Share | -1.10 | -1.92 | -8.45 | -16.77 | -17.09 | -20.71 | Upgrade |
Gross Margin | 11.91% | 16.63% | 33.24% | 26.52% | 39.59% | 33.30% | Upgrade |
Operating Margin | -224.00% | -240.21% | -204.36% | -302.97% | -132.79% | -948.53% | Upgrade |
Profit Margin | -293.46% | -317.74% | -483.50% | -260.24% | -109.48% | -1245.12% | Upgrade |
Free Cash Flow Margin | -113.33% | -158.38% | -116.21% | -270.16% | -92.94% | -772.71% | Upgrade |
EBITDA | -29.98 | -32.56 | -46.82 | -51.61 | -31.11 | -26.32 | Upgrade |
EBITDA Margin | -168.12% | -176.18% | -167.56% | -264.36% | -129.38% | - | Upgrade |
D&A For EBITDA | 9.96 | 11.84 | 10.28 | 7.54 | 0.82 | 1.77 | Upgrade |
EBIT | -39.94 | -44.4 | -57.1 | -59.14 | -31.93 | -28.09 | Upgrade |
EBIT Margin | -224.00% | -240.21% | -204.36% | - | -132.79% | - | Upgrade |
Advertising Expenses | - | 0.14 | 0.11 | 0.3 | 0.7 | 0.67 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.